ICD-10 category · Morphology of neoplasms · M814-M838
M831 Adenomas and adenocarcinomas
22 codes under M831 in the South African Master Industry Table 2021, 22 valid for clinical use.
| Code | Description | Use | Benefits |
|---|---|---|---|
| M8310/0 | Clear cell adenoma, benign | Valid · not as primary | — |
| M8310/3 | Clear cell adenocarcinoma, NOS, malignant, primary site | Valid · not as primary | — |
| M8310/6 | Clear cell adenocarcinoma, NOS, malignant, metastatic site | Valid · not as primary | — |
| M8311/1 | Hypernephroid tumour, uncertain whether benign or malignant | Valid · not as primary | — |
| M8312/3 | Renal cell carcinoma, NOS, malignant, primary site (C64) | Valid · not as primary | — |
| M8312/6 | Renal cell carcinoma, NOS, malignant, metastatic site | Valid · not as primary | — |
| M8313/0 | Clear cell adenofibroma, benign | Valid · not as primary | — |
| M8313/1 | Clear cell adenofibroma of borderline malignancy, uncertain whether benign or malignant | Valid · not as primary | — |
| M8313/3 | Clear cell adenocarcinofibroma, malignant, primary site (C56) | Valid · not as primary | — |
| M8313/6 | Clear cell adenocarcinofibroma, malignant, metastatic site | Valid · not as primary | — |
| M8314/3 | Lipid-rich carcinoma, malignant, primary site (C50.-) | Valid · not as primary | — |
| M8314/6 | Lipid-rich carcinoma, malignant, metastatic site | Valid · not as primary | — |
| M8315/3 | Glycogen-rich carcinoma, malignant, primary site (C50.-) | Valid · not as primary | — |
| M8315/6 | Glycogen-rich carcinoma, malignant, metastatic site | Valid · not as primary | — |
| M8316/3 | Cyst-associated renal cell carcinoma, malignant, primary site (C64) | Valid · not as primary | — |
| M8316/6 | Cyst-associated renal cell carcinoma, malignant, metastatic site | Valid · not as primary | — |
| M8317/3 | Renal cell carcinoma, chromophobe type, malignant, primary site (C64) | Valid · not as primary | — |
| M8317/6 | Renal cell carcinoma, chromophobe type, malignant, metastatic site | Valid · not as primary | — |
| M8318/3 | Renal cell carcinoma, sarcomatoid, malignant, primary site (C64) | Valid · not as primary | — |
| M8318/6 | Renal cell carcinoma, sarcomatoid, malignant, metastatic site | Valid · not as primary | — |
| M8319/3 | Collecting duct carcinoma, malignant, primary site (C64) | Valid · not as primary | — |
| M8319/6 | Collecting duct carcinoma, malignant, metastatic site | Valid · not as primary | — |
Source and terms
Reproduced from the national table, unaltered.
The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page
Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.
ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.
Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.
Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.
In GreenNotes
Code the consultation once. The invoice and the claim pick it up.
GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.